Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company dedicated to enhancing the diagnosis and treatment of cancer and other diseases through real-time in vivo microscopic visualization. The company's primary product, Cellvizio, is an innovative imaging platform designed for optical biopsies, allowing physicians to view tissues at a cellular level during standard medical procedures. This technology enables more accurate detection of early-stage pathologies, facilitating informed therapeutic decisions. Mauna Kea Technologies markets its products internationally, having received regulatory clearance for a variety of applications in the United States and over 40 other countries. The company generates revenue through the sale of Cellvizio devices and related accessories for medical diagnostics and research.